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The P-type ATPases family consists of ion and lipid transporters. Their unique diversity in
function and expression is critical for normal development. In this study we investigated
human pluripotent stem cells (hPSC) and different neural progenitor states to characterize
the expression of the plasma membrane calcium ATPases (PMCAs) during human
neural development and in mature mesencephalic dopaminergic (mesDA) neurons. Our
RNA sequencing data identified a dynamic change in ATPase expression correlating
with the differentiation time of the neural progenitors, which was independent of the
neuronal progenitor type. Expression of ATP2B1 and ATP2B4 were the most abundantly
expressed, in accordance with their main role in Ca2+ regulation and we observed all of
the PMCAs to have a subcellular punctate localization. Interestingly in hPSCs ATP2B1
and ATP2B3 were highly expressed in a cell cycle specific manner and ATP2B2 and
ATP2B4 were highly expressed in a hPSC sub-population. In neural rosettes a strong
apical PMCA expression was identified in the luminal region. Lastly, we confirmed all
PMCAs to be expressed in mesDA neurons, however at varying levels. Our results reveal
that PMCA expression dynamically changes during stem cell differentiation and highlights
the diverging needs of cell populations to regulate and properly integrate Ca2+ changes,
which can ultimately correspond to changes in specific stem cell transcription states.
Keywords: plasmamembrane calciumATPase, human pluripotent stem cells, neural stem cells, neuromesodermal
progenitors, mesencephalic dopaminergic neurons
INTRODUCTION
Cytosolic Ca2+ is an abundant intracellular second messenger involved in many cellular processes.
A diverse array of proteins are able to bind to Ca2+ each with a varying range in affinity, fromwhich
the calcium binding can alter the protein’s shape and charge, resulting in a potential functional
change and alteration in cellular signaling. As such, of particular importance are the Ca2+ P-type
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ATPases, the plasma membrane calcium ATPases (PMCAs) and
the sarco/endoplasmic reticulumCa2+ATPase (SERCAs), which
reside in different compartments of the cell and along with other
Ca2+ transporting system contribute to the regulation of the
intracellular Ca2+ concentration.
The PMCA’s ability to extrude and regulate Ca2+ levels is
critical for cellular function and in turn the precise regulation of
PMCA expression is also essential. The C-terminal of the PMCA
is the main regulatory site of its pump and contains a calmodulin
(CaM) binding domain and phosphorylation sites (Penniston
and Enyedi, 1998; Brini and Carafoli, 2011; Tidow et al., 2012).
Increased intracellular Ca2+ results in CaM stimulating pump
activity by bending the C-terminal regulatory domain away
from the active site of the pump releasing it from the auto-
inhibitory state (Brini and Carafoli, 2011; Tidow et al., 2012).
Phosphorylation in the regulatory C-terminal is executed by both
Protein Kinase A (PKA) and Protein Kinase C (PKC); PKA
stimulate Ca2+ extrusion, whereas PKC inhibits (James et al.,
1989; Enyedi et al., 1997). PKC conducts its inhibitory effect by
phosphorylation of the CaM binding domain, creating a barrier
for CaM interaction and hereby inhibiting CaM stimulation
(Enyedi et al., 1997). PMCA regulation of Ca2+ is therefore
crucial in fine-tuning the levels of Ca2+ in the cytoplasm
with sequence variability, splice variants, and cell type specific
expression seen between the different PMCA isoforms all having
varying effects on the multitude of affected signaling pathways.
Regulation of signaling pathways by Ca2+ occurs at the earliest
stages of development where it plays a critical role in fertilization
and hPSC maintenance (Deguchi et al., 2000; Todorova
et al., 2009). Furthermore, Ca2+ has been interconnected
with several neural properties such as synaptic transmission
and long-term potentiation and dysregulation of intracellular
calcium due to altered PMCA expression has been shown to
affect neural differentiation through their involvement in Fgf
and Wnt signaling (Brini et al., 2014; Abdul-Wajid et al.,
2015; Boczek et al., 2015). Different PMCA genes maintain
different expression profiles. In humans ATP2B1 and ATP2B4
are expressed throughout the body, whereas the two other
isoforms, ATP2B2 and ATP2B3, exhibit neural and muscular
tissue specific expression (Stauffer et al., 1995). Mutations in
ATP2B1 is embryonic lethal and mutations in ATP2B2-4 have
been correlated with different neuronal deficits: hearing loss,
congenital ataxias, and familial spastic paraplegia, respectively
(Okunade et al., 2004; Ficarella et al., 2007; Zanni et al., 2012;
Ho et al., 2015). These studies highlight the important role of the
various PMCAs in Ca2+ handling across the diverse cell types,
therefore identifying their cell type specific expression during
development is crucial for understanding cell type specific Ca2+
regulation.
The precise localization and neural specific expression of
PMCAs during the development of the human nervous system
is poorly understood. To address this we used hPSCs to
generated neural stem cells (NSCs) of the central and peripheral
nervous system and investigated the main neural progenitor
states for the presence of PMCAs using RNA sequencing (RNA-
seq) and immunofluorescent labeling. Our results uncovered a
dynamic change in ATPase expression that correlates directly
with the stage of differentiation. Furthermore, PMCA expression
was not only altered between stem cell states, but also in
addition showed unique cell cycle specific changes. Lastly
due to the importance of Ca2+ regulation in Parkinson’s
disease (PD) we differentiated the NSC further and generated
mesencephalic dopaminergic (mesDA) neurons to characterize
the presence of PMCA proteins (Schöndorf et al., 2014). These
data have important implications for understanding the role
of Ca2+ in development and potentially how disease states,
which disrupted Ca2+ homeostasis, can result in global cellular
dysfunction.
MATERIALS AND METHODS
Human Pluripotent Stem Cell Culture
H9 (WA-09, WiCell) and iPSC-CCD (reprogrammed from
human Foreskin fibroblasts, ATCC) cell lines were cultured
as previously described (Denham and Dottori, 2011). Briefly,
hESCs and hPSCs were cultured on irradiated human foreskin
fibroblasts (HFF) in KSR media consisting of DMEM/nutrient
mixture F-12, supplemented with β-mercaptoethanol 0.1mM,
non-essential amino acids (NEAA) 1%, glutamine 2mM,
penicillin 25 U/ml, streptomycin 25µg/ml, and knockout serum
replacement 20% (all from Life Technologies), supplemented
with FGF2 (10 ng/ml; Peprotech) and Activin A (10 ng/ml;
R&D systems). All cells were cultured at 37◦C 5% CO2.
Colonies were mechanically dissected every 7 days and
transferred to freshly prepared HFF. Media was changed every
second day.
Neural Stem Cell Differentiation
hESCs or hPSCs were mechanically dissected into pieces
∼0.5mm in diameter and transferred to laminin-coated organ
culture plates in N2B27 medium containing 1:1 mix of
neurobasal medium with DMEM/F12 medium, supplemented
with insulin/transferrin/selenium 1%, N2 1%, retinol-free B27
1%, glucose 0.3%, penicillin 25 U/ml, and streptomycin 25µg/ml
(all from Life Technologies) for 11 days. Cultures were grown on
laminin for the first 4 days after which they were dissected into
0.5mm pieces and cultured in suspension in low-attachment 96-
well plates (Corning) in N2B27 medium. For neural epithelial
progenitors (NEP) specification SB431542 (SB; 10µM, Tocris)
was added to the media and cells were collected at day 4. To
further specify the cells to rostral neural stem cell (NSC), NEP
were generated and then further cultured to day11 in the absence
of SB and supplemented with FGF2 (20 ng/ml; Peprotech).
For neuromesodermal progenitors (NMP) induction, NEP
induction was performed as above and cultures were additionally
supplemented with GSK3β inhibitor CHIR99021 (CHIR; 3µM,
Stemgent) from days 0 to 4. For neural crest stem cells (NCSCs)
specification NMP induction was performed and from days
4 to 11 cultures were supplemented with FGF2 (20 ng/ml;
Peprotech) and BMP2 (50 ng/ml; Peprotech). For caudal NSC
specification NMP induction was performed and from days
4 to 11 cultures were supplemented with FGF2 (20 ng/ml;
Peprotech).
Frontiers in Cell and Developmental Biology | www.frontiersin.org 2 February 2018 | Volume 6 | Article 5
Chen et al. PMCAs in Human Neural Development
Mesencephalic Dopaminergic Neuron
Differentiation
Generation of mesDA neurons was achieved by modification of
previous described protocols (Denham et al., 2012; Kirkeby et al.,
2012). Briefly, from day 0 to day 9 cells were grown in N2B27
media with 10µM SB431542, 0.7µMCHIR99021, 0.1µM LDN-
193189 (Stemgent), and 400 nM SAG (Millipore), day 4 to day 9
basal media change to ½ N2B27. At day 9 to day 11, the media
was changed to ½ N2B27 without small molecules. From Day
11 the cells were grown in Neurobasal media supplemented with
B27 1%, Pen/Strep 25 U/mL, Glutamax 0.5%, 200µM Ascorbic
Acid (AA) (Sigma-Aldrich) and grown on culture plate coated
with polyornithine, fibronectin, and laminin (all from Sigma).
From day 14, 2.5µM DAPT (Tocris bioscience) was added into
the culture media. The media was changed every second day and
samples were collected on day 45.
Immunolabeling
Cell monolayers and neurospheres were fixed in 4% PFA for
20min at 4◦C and then washed briefly in PBS. Neurospheres
were embedded in Tissue-Tek OCT compound (Labtek), cut at
10µm on a cryostat, and sections were placed on superfrost
slides. Sections or culture dishes were blocked for 1 h at
room temperature (RT) in blocking solution. The following
primary antibodies were used: goat anti-Sox10 (1:100, R&D
systems), goat anti-Sox2 (1:100, R&D), mouse anti-Sox2 (1:100
R&D), mouse anti-Oct4 (1:100, Santa Cruz), mouse anti-
Nanog (1:100, eBioscience), mouse anti-ßIII-tubulin (1:1,000,
Millipore), goat anti-FOXA2/HNF3Beta (1:500, Santa Cruz),
mouse anti- Tyrosine hydroxylase (TH, 1:2000, Millipore),
rabbit anti-ATP2B1 (1:1,000, SWANT) (Stauffer et al., 1995,
1997), goat anti-ATP2B2 (1:200, S-18 sc-22073, Santa Cruz)
(Sahly et al., 2012), rabbit anti-ATP2B3 (1:1000, SWANT)
(Stauffer et al., 1995, 1997), and goat anti-ATP2B4 (1:200, Y-
20 sc-22080, Santa Cruz) (Patel et al., 2013). Antibodies were
diluted in blocking solution incubated on sections and cultures
overnight at 4◦C. Following three 10-min washes in PBT, the
corresponding Alexa Fluor-647, Alexa Fluor-488 or Alexa Fluor-
594 donkey secondary antibodies were applied for 1 h at RT
(1:400, Jackson ImmunoResearch). Nuclei were counterstained
with 49,6-diamidino-2-phenylindole (DAPI; 1µg/ml, Sigma).
Slides were mounted in PVA-DABCO for viewing under a
fluorescent microscope (ZEISS ApoTome), and images captured
using the ZEN software. Confocal microscopy was performed
using a ZEISS LSM 780 Confocal Microscope. The images were
reconstructed as an intensity projection over the Z-axis using
ZEN software.
RNA Sequencing
RNA sequencing was performed in collaboration with BGI-
Research, Shenzhen, China. Briefly, total RNA was first assessed
with Agilent 2100 Bioanaylzer and treated with DNase I.
Magnetic beads with Oligo dT were used to isolate mRNA.
The mRNA was then fragmented into short fragments with
fragmentation buffer and complement DNA (cDNA) was
synthesized using the mRNA fragments as templates. Short
fragments were purified with EB buffer for end reparation
and single nucleotide A (adenine) addition. After that, the
short fragments were linked to adapters. After agarose gel
electrophoresis, the suitable fragments were selected for the PCR
amplification as templates. During the QC steps, Agilent 2100
Bioanaylzer and ABI StepOnePlus Real-Time PCR System were
used for quantification and qualification of the sample library.
Finally, the library was sequenced using Ion proton platform.
Raw data from the Ion proton was subjected to data QC. Raw
reads were filtered into clean reads and aligned to the reference
gene with TMAP to calculate distribution of reads on reference
genes and perform coverage analysis. At the same time, the clean
reads were aligned to ref genome (hg19) with TopHat for a
series of subsequent analysis. Finally, gene expression level and
differential expression analysis was performed.
Statistical Analysis
One-way ANOVAs and post-hoc analyses were performed
for statistical analyses on RPKM values using GraphPad
Prism 6. To generate Heatmaps, RPKM values were log2
transformed and mean centered and graphed using R studio with
heatmap.2. Principal components were calculated by singular
value decomposition of the centered and scaled data matrix using
the prcomp function in R stats package.
RESULTS
Profiling of ATPase Expression in Human
Embryonic Stem Cells and in Early Neural
Stem Cell States by RNA Sequencing
We first set out to characterize ATPase transcripts in hESCs
and hESC-neural derivatives, including early NSCs of the central
and peripheral nervous system. To generate CNS and PNS
progenitors we implemented our previously described protocol
(Denham et al., 2012, 2015). Day 4 NEPs along with the
subsequent day 11 rostral NSCs were derived (Figure 1A).
Additionally NMPs were generated and by further differentiating
the day 4 NMPs in two distinct ways, caudal neural progenitors
(day11; CNPs) and day 11 NCSCs were derived (Figure 1A).
With these 6 distinct time points we set out to validate the
gene expression of these populations by RNA-seq analysis
(undifferentiated hESC and the five NSC states: NEP, NMP,
rostral NSC, caudal NSC, and NCSC). Firstly we examined the
gene expression of known markers indicative of the various
stem cell states. As expected we identified POU5F1 (previously
known as OCT4) and NANOG as highly expressed in the
undifferentiated hESCs and down-regulated in all of the neural
populations: SOX2 was maintained throughout all progenitor
states (Figure 1B). Furthermore, day 4 NEP expressed transcripts
indicative of anterior identity, such as OTX2, SIX3, and LHX2.
Rostral NSCs expressed high levels of SOX1, OTX2 FOXG1,
SIX3, and LHX2. NMPs as previously described are known to
co-express T and Sox2 (Tzouanacou et al., 2009; Gouti et al.,
2014; Turner et al., 2014; Denham et al., 2015). In accordance
with this we detected both high levels of T and SOX2 in NMPs
and we also detected NKX1-2 and FOXB1 (Figure 1B; Turner
et al., 2014). Caudal neural markers were also detected such
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FIGURE 1 | RNAseq profiling of ATPase expression in human embryonic stem
cells and in early neural stem cell states. (A) Overview of protocol for deriving
neural epithelial progenitors (NEP), and neuromesodermal progenitors (NMP)
on day 4; rostral neural stem cells (NSC), neural crest stem cells (NCSCs) and
caudal NSC on day 11. (B) Gene expression of known markers indicative of
the various stem cell states. (C) Principal component analysis of expression of
ATPases during early neural progenitor states. (D) RNAseq profiling of
ATP2B1-4 expression (in RPKM values) in human embryonic stem cells and in
early neural stem cell states (****p < 0.001). Not all significant differences are
indicated. Legend shown in (D) also represents colored dots in (C).
as HOXA1 in the NMP state. Caudal NSCs expressed IRX3
and HOXD4, additional HOX genes were also expressed with
the most caudal representing the lumbar regions of the spinal
cord (Figure 1B; Figure S1). NCSCs expressed the crest marker
SOX10, TFAP2B, FOXD3, PAX3, and POU4F1 (previously known
as BRN3A).
To explore the variation in expression of ATPases during early
neural progenitor states we performed a principal component
analysis on all ATPases. Strikingly we observed that principal
component 1 (PC1), which had the highest percentage of variance
(30.4%) separated the stem cell states based on the time of
differentiation, whereas the PC2 could separate only some of the
stem cell states at each time point (Figure 1C). These results
indicated that a dynamic change in ATPase expression occurs
between the distinct progenitor states, progressively changing
as the neural progenitors developed toward more committed
progenitors.
Based on these results we further sought to examine the P-
type ATPase PMCA members (ATP2B1-4; Figure 1D). ATP2B1-
4 were all examined between each of the stem cell states.
ATP2B1 and ATP2B4 had higher amount of transcripts across
all of the stem cell populations (Figure 1D). Interestingly the
ATP2B1 expression significantly increased (p < 0.0001) when
differentiated from the pluripotent state to both NEP and NMP
day4 progenitor states. In the NEP group ATP2B4 expression was
also significantly increased compared to the pluripotent state (p
< 0.0001; Figure 1D). ATP2B2 and ATP2B3 were also detected,
in all groups, except for in the NMP group where ATP2B2 was
undetected (Figure 1D).
PMCA Expression in Human Pluripotent
Stem Cells
We next investigated whether the expression of PMCAs, as
indicated by RNAseq analysis (Figure 1D), were translated into
detectable protein levels and to subsequently determine the
cell subtype specific expression. ATP2B1-4 were all detected
in pluripotent stem cells and showed a punctate localization
pattern within the cells (Figure 2). ATP2B1 was ubiquitously
expressed and interestingly vastly higher amounts were seen
in dividing cells that also maintained expression of POU5F1
(Figure 2, arrow head). To further validate the pluripotent
status of these cells NANOG expression was analyzed and,
indeed, high ATP2B1 expressing cells also co-expressed NANOG
(Figure S2).
In contrast, ATP2B2 expression was more restricted to
a subpopulation of the hPSCs that could be identified
also by an atypical morphology, consisting of a larger
cytoplasm to nuclear ratio. Despite this morphology, POU5F1
and NANOG were both expressed in the ATP2B2 positive
cells within the pluripotent culture. Notably however these
cells were frequently located closer to the edges of the
colony.
ATP2B3 showed a similar ubiquitous expression pattern
to ATP2B1 and higher expression in dividing cells. However,
interestingly, not all dividing cells expressed higher levels
of ATP2B3, potentially representing a discrete stage during
mitosis (Figure 2). Furthermore, ATP2B3 positive cells expressed
POU5F1 and NANOG (Figure 2, Figure S2). Lastly we identified
ATP2B4 positive cells that corresponded with a population close
to the edge of the colony, with all positive cells having a large
cytoplasm similar to ATP2B2 (Figure 2). Moreover, these cells
also still expressed POU5F1 and NANOG.
Based on our analysis of hPSCs, all PMCAs were expressed in
pluripotent, POU5F1 and NANOG positive, cells. The expression
of PMCAs varied, however, with respect to cell morphology and
cell cycle stage, with the most notable change being ATP2B1 and
ATP2B3 expression being highest during cell division, a point at
which cell differentiation can occur. Overall, precise regulation
of Ca2+ by PMCAs could be required during mitosis in hPSCs.
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FIGURE 2 | Immunocytochemistry analysis of ATP2B1-4 and POU5F1 expression in human pluripotent stem cells. Arrow heads point to the dividing cells.
Scale bars = 20µm.
Furthermore, ATP2B2 andATP2B4were highly expressed in cells
withmorphologies indicative of ametastable differentiation state.
PMCA Expression in Early Neural Stem
Cells
Differentiation of pluripotent stem cells toward a neuroectoderm
fate coincides with transient increases in intracellular Ca2+.
Based on our RNAseq data we identified a significant change
in expression between pluripotent and day 4 time points for
ATP2B1 (Figure 1D). Additionally, the higher expression of
PMCAs in morphologically larger hPSCs and during cell division
indicates a changing cellular state with varying requirements
for Ca2+ regulation. We therefore further investigated the
PMCA protein expression and localization during neural
development. NEPs and NMPs were examined, which represent
progenitors of the same differentiation time point but with
vastly different potential (Figures 3A,B). PMCA expression
in NEPs and NMPs were indiscernible from each other,
both populations showing ubiquitous expression throughout
the cultures for ATP2B1. In contrast to the RNAseq data,
ATP2B2 was detected in both groups and it was mainly
detected in dividing cells and also found in discrete sub-
populations of cells, which SOX2 could not discriminate. In
both groups ATP2B3 was ubiquitously expressed but at lower
levels consistent with the RNAseq analysis. The ATP2B4 was
strongly expressed in cell membranes of a sub-population of
cells, however SOX2 expression could also not separate this
population.
PMCA Expression in Central and
Peripheral Neural Stem Cells
We further characterized the PMCA expression at later
differentiation states, the Rostral NSCs, Caudal NSCs and
NCSCs (Figures 4A–C). In accordance with the RNAseq
data and consistent with the early stem cell states all PMCA
genes were detected within all groups. Interestingly in all
three groups ATP2B1 expression was apically localized
to the luminal regions of the neural rosettes, which also
co-stained for SOX2. Furthermore, ATP2B2 within the
Rostral NSCs was also apically localized to the luminal
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FIGURE 3 | Immunocytochemistry analysis of ATP2B1-4 and SOX2
expression in (A) neural epithelial progenitors (NEP) and in (B)
neuromesodermal progenitors (NMP) on day 4. Scale bars = 20µm.
region of the rosettes and within the NCSCs ATP2B2 was
selectively localized to the SOX2 positive cells. ATP2B4
expression was higher at the edges of the spheres except for
the Caudal NSC groups, which showed a more ubiquitous
expression.
PMCA Expression in Mesencephalic
Dopaminergic Neurons
Having identified the changing expression between the
maturation states of the NSC we lastly sought to characterize
the expression of PMCAs in mature neurons. We therefore
investigated PMCA expression in mesDA neurons. mesDA
neurons were differentiated in vitro for 45 days following our
previously established protocol (Figure 5A). We first validated
the protocol by staining differentiated cell populations with
FOXA2 and Tyrosine Hydroxylase (TH), markers indicative
of mesDA neurons, and identified neurons positive for both
markers (Figure 5B). ATP2B1 was highly expressed and localized
to the soma and the axons of the dopaminergic neurons. ATP2B2
and ATP2B3 were also expressed throughout the TH+ neurons,
whilst ATP2B4 was detected weakly in the mesDA neurons
(Figure 5).
DISCUSSION
Calcium acts as a major second messenger system within cells
and as such it is involved in the regulation of numerous
signaling pathways. During development stem cell fate is dictated
by the precise temporal and spatial activation of signaling
events, which requires specific ligand-receptor interactions and
can rely on cytoplasmic calcium for transcriptional regulation
(Lee et al., 2009; Thrasivoulou et al., 2013). This study has
identified the expression changes of PMCAs that occur during
early human stem cell states of the developing nervous system.
In particular we have characterized the expression of PMCAs
within: hPSCs, NEPs, NMPs, Rostral NSCs, Caudal NSCs, and
NCSCs. Strikingly we observed a dynamic change in ATPase
expression that coincided with the advanced differentiation states
of NSC, which was independent of the differentiation of the
NSCs (Figure 1C). We identified ATP2B1 and ATP2B4 as the
most abundantly expressed, consistent with previous reports
in other cell types and with ATP2B1 regarded as providing a
housekeeping function for Ca2+ homeostasis (Okunade et al.,
2004). Furthermore, ATP2B1 expression significantly increased
when differentiating from a pluripotent state to either a NMP
or NEP, indicated a change in the transcriptional regulation
of ATP2B1 when transitioning to neural ectoderm. In contrast
to ATP2B1 and ATP2B4, the RPKM values of ATP2B2 and
ATP2B3 were lower and ATP2B2 was undetected in NMP.
Despite the absence of detected transcripts, ATP2B2 proteins
could be detected in NMPs, which was a sub-population of
mainly dividing cells (Figure 1D). The depth of sequencing
and the fact that ATP2B2 was only observed in a small
subpopulation is the likely reason for the discrepancies between
the sequencing and immunostaining results. Moreover, the
differences between the RNAseq data and immunostaining
results reflects the known divergence in transcript production
and half-life to that of protein synthesis and turnover (Maier
et al., 2009). Furthermore, our immunostaining also revealed
a subcellular punctate localization for all the PMCAs, which
suggests that the localization rather than the abundant of
PMCAs are important for normal cellular function. The punctate
localization of the PMCAs is likely formed to produce specific
signaling complexes, which has been reported previously for
ATP2B1-4, and the C-terminal tail of ATP2B4 has been shown
to act as a signaling peptide involved in controlling its cellular
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FIGURE 4 | Immunocytochemistry analysis of ATP2B1-4 and SOX2 or SOX10 expression in (A) rostral neural stem cells (NSC), in (B) caudal NSC, and in (C) neural
crest stem cells (NCSCs) on day 11. Scale bars = 20µm.
localization (Marcos et al., 2009; Kenyon et al., 2010; Antalffy
et al., 2013).
In contrast to mouse embryonic stem cells, which have
been shown to only express ATP2B1 and ATP2B4, we
identified a transient pluripotent state with an atypical
morphology that express ATP2B2 and still expressed
POU5F1 and NANOG (Figure 2, Figure S2; Yanagida
et al., 2004). These ATP2B2 expressing pluripotent stem
cells may represent a primed state of hPSCs committed
to differentiate but not yet having down-regulated all
pluripotency genes (Kalkan et al., 2017; Liu et al., 2017;
Smith, 2017).
Interestingly, in pluripotent cultures, ATP2B1 and ATP2B3
were highly expressed in cells undergoing mitosis. Both ionic
current and PMCA activity have been shown to fluctuate
during mitosis in the development of simpler eukaryotes
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FIGURE 5 | Immunocytochemistry analysis of ATP2B1-4 expression in
mesencephalic dopaminergic neurons. (A) Overview protocol for making
mesDA in vitro for 45 days. (B) Immunostaining of mesDA with double positive
of FOXA2 and Tyrosine Hydroxylase (TH) markers indicates the efficient
protocol. (C) Immunostaining of ATP2B1-4 and TH expression. Arrow heads
point to the TH positive staining with ATP2B1-4 staining and white lines in
ATP2B1-4 panels outlines TH positive staining. Scale bars = 20µm.
(Zivkovic et al., 1991). Moreover, prevention of Ca2+ surges
prior to or during mitosis result in inhibition of mitosis entry
and exit, respectively (Steinhardt and Alderton, 1988). Thus,
regulation of Ca2+ surges seems to be essential for cell division.
Interestingly we could observe increased ATP2B1 and ATP2B3
in a period close to or during the anaphase-telophase transition,
a stage which is dependent on a sustained increased Ca2+ level
(Tombes and Borisy, 1989). Furthermore, nuclear Ca2+ can
operate in an independent manner within the nucleus to that of
the cytoplasm through the regulation of its own Ca2+ stores, with
nuclear InsP3 being capable of regulating nuclear Ca2+ levels
(Leite et al., 2003). In accordance with this, the cell cycle specific
expression of PMCAs likely represents an altered requirement
of cytoplasmic calcium regulation during nuclear envelope break
down in cytokinesis (Stehno-Bittel et al., 1995).
Previous studies have identified ATP2B2 and ATP2B3 to be
predominantly expressed in neuronal tissues (Stauffer et al., 1995;
Strehler and Zacharias, 2001). Consistent with that we detected
all PMCA isoforms in both NEPs and NMPs. Interestingly, at
later stages in neural development we found ATP2B1 to be
apically localized to the luminal regions of the neural rosettes.
Active Ca2+ secretion to the lumen of the neural rosettes could be
required for the generation of a specific lumen environment that
promote neural tube closure (Abdul-Wajid et al., 2015; Suzuki
et al., 2017). Furthermore, we identified ATP2B4 to be highly
expressed at the edges of the neurospheres in the Rostral NSC
and NCSC groups, however we could not identify a specific
protein marker that could define this population. Nevertheless,
an explanation for this could be that PMCA expression can be
altered by changes in physical environmental rather than cell
identity (Antalffy et al., 2013).
Dopamine release by mesDA neurons is dependent on
precise Ca2+ fluctuations (Sgobio et al., 2014). We found that
mesDA neurons expressed all four PMCAs. Alterations therefore
in PMCA expression in mesDA neurons could contribute to
mesDA neurons increased sensitivity to Ca2+ and hence to
the PD pathogenesis. In support of this, impairment of Ca2+
homeostasis has been observed in iPSC-derived mesDA neurons
from patients with heterozygous mutations for GBA1 (Schöndorf
et al., 2014). These neurons showed an increase in basal Ca2+
levels and increased vulnerability to Ca2+ mediated endoplasmic
reticulum (ER) stress. In addition, in PMCA overexpressing rats
a neuroprotective function of PMCAs has been shown by its
ability to decrease vulnerability to MPTP treatment (Brendel
et al., 2014). Hence, strategies to regulate PMCA activity could
serve as a neural protective mechanism in mesDA neurons by
providing additional support for intracellular Ca2+ regulation.
CONCLUSION
In summary, we have identified a dynamic change in the
expression of P-type ATPases between distinct progenitor types.
The transcriptional mechanisms that regulate these changes is
still unknown and the functional significance of progenitor cell
types requiring distinct P-type ATPase expression has yet to
be elucidated, however it may reflect cell type specialization
requirements. Most significantly we identified a novel expression
timing of ATP2B1 and ATP2B3 during cell division of hPSCs
and expression of ATP2B2 was observed in a subpopulation of
hPSCs. Neural rosettes were identified as having a distinct apical
localization of ATP2B1 to their luminal side. Lastly, we identified
ATP2B1-4 were all expressed in mesDA neurons. Overall these
results contribute to our understanding of the respective roles of
the PMCA isoforms in neural development and their potential
use as drug target for disease therapies.
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